When you buy through links on our articles, Future and its syndication partners may earn a commission.

Scientists discover that loss of MTAP gene disables immune defenses in tumors; DFMO drug could reactivate STING pathway.

While the AI world is busy pitching visions of utopia, Google’s lab lights remain on, deep into the night While others love grandstanding about “solving world hunger” or “curing cancer,” Google ...

In the current study, the association between mRNA COVID vaccination and survival was strongest among patients whose tumors ...

Trageting abnormal brain cells linked to chronic inflammation may be key to treating people with progressive forms of MS, a ...

Saphnelo can now be administered subcutaneously rather than intravenously following the European regulator’s recommendation.

AstraZeneca has received the green light from European regulators for its Saphnelo treatment for lupus, the pharma giant ...

Google's AI model proposes a novel drug combination for cancer detection, marking a milestone in AI-driven scientific ...

Results of a study led by researchers at Roswell Park Comprehensive Cancer Center are shedding light on why some newly ...

DNTH212 is a bifunctional fusion protein targeting plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while ...

DNTH212 is a bifunctional fusion protein targeting plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while simultaneously inhibiting BAFF/APRIL to suppress B cell ...

Scale” model spotted a drug combination that made tumors more visible to the immune system, a breakthrough Google calls “a ...